This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

MLex Comment: Merger referral rules will come under scrutiny as EC weighs SC Johnson merger veto

By Robert McLeod and Dafydd Nelson ( April 29, 2011, 14:47 GMT | Comment) -- SC Johnson’s planned buyout of Sara Lee’s household insecticides business is hanging in the balance as the European Commission’s in-depth probe of the tie-up heads to a conclusion. While an outright veto is not beyond the realms of possibility, such a decision should force a judicial review of the interpretation of the rules that allowed the commission to get jurisdiction over the deal in the first place.SC Johnson’s planned buyout of Sara Lee’s household insecticides business is hanging in the balance as the European Commission’s in-depth probe of the tie-up heads to a conclusion. While an outright veto is not beyond the realms of possibility, such a decision should force a judicial review of the interpretation of the rules that allowed the commission to get jurisdiction over the deal in the first place....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login